about
Mechanisms involved in antibody- and complement-mediated allograft rejectionSensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts.Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage.Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complementImproved in vitro blood compatibility of polycaprolactone nanowire surfaces.A novel liposome-based therapy to reduce complement-mediated injury in revascularized tissues.Mesenchymal stem cells engineered to inhibit complement-mediated damage.Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejectionGene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching.Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac TransplantAllograft outcomes in outbred mice.T-cell regulation: with complements from innate immunity.Genotypic variation and outcomes in kidney transplantation: donor and recipient effects.Regenerative medicine: prospects for the treatment of inflammatory bowel disease.Xenotransplantation: immunological hurdles and progress toward tolerance.Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.Thrombin may modulate dendritic cell activation in kidney transplant recipients with delayed graft function.Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival.Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial
P2860
Q24629268-E3840431-110D-4B5B-B752-2441DF28A658Q30317554-F6513610-281B-4689-B046-55D823EBE70AQ33214939-09E1F525-E4D5-4F5F-874C-D0C6D1901CC3Q33745120-14C23DF3-1FBA-45D6-BB5B-54EADD46A217Q33873704-5D9AD199-A49C-460B-8A9F-2E2EF0792E40Q34237615-834709D3-5258-48A6-9B68-9ADCCD78FBE5Q34423372-01557DA2-0D4C-4E93-9C5D-171A52A4D17CQ34653955-518AC80C-0F83-41CC-BBB9-E6A698F8A55EQ35088132-E842E7F0-98C6-471A-B5FB-84650A4AA3B8Q35541507-C740B883-D801-4714-A2AF-2F7F22D855B6Q35574072-8721AA9C-B2D8-4BC9-BB9D-B0804241D816Q36302489-48E851AA-7148-489C-A39A-45A35DF812EFQ36639676-D491BC50-6C36-4DF6-83C0-395C050E22E6Q36684909-C35E0B05-5049-4F80-B8A3-2983435B0738Q37142948-E4FD8579-41B2-4FB6-B6AB-E44ED7B86158Q38133660-4EF18229-B93A-4207-B21D-950793682F3EQ38187179-86459123-3173-4B44-8F3B-45BB10DDF964Q38592520-EC36FEAA-7E00-4230-A32A-572187A30163Q40856216-D6D06815-A3A7-410D-B6E7-DA7D4F36941BQ47115111-E30D13F1-2A80-430F-94A1-8F3212545FFDQ53475097-06F4F407-3AF4-45FE-8EA9-CD444F23C645Q58378349-AD6E3EBE-A032-47C6-8759-DF985D6AE84F
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of the complement system in rejection.
@ast
Role of the complement system in rejection.
@en
Role of the complement system in rejection.
@nl
type
label
Role of the complement system in rejection.
@ast
Role of the complement system in rejection.
@en
Role of the complement system in rejection.
@nl
prefLabel
Role of the complement system in rejection.
@ast
Role of the complement system in rejection.
@en
Role of the complement system in rejection.
@nl
P1476
Role of the complement system in rejection
@en
P2093
Paramit Chowdhury
Wuding Zhou
P304
P356
10.1016/S0952-7915(03)00100-6
P577
2003-10-01T00:00:00Z